HIGHFDA DEVICE

Foundation Medicine FoundationOne CDx Recalled for Missing Companion Diagnostic Claims Page

Foundation Medicine recalled 59 units of FoundationOne CDx (F1CDx), RAL-0003 version 31.0 after reports indicated the companion diagnostic Claims Page was omitted. This oversight could impact patient care and healthcare provider decisions concerning diagnosis and treatment. Users should stop using the device and contact Foundation Medicine or their healthcare provider for further instructions.

Official notice
Foundation MedicineHealth & Personal CareMedical DevicesF1CDX - RAL-0003 version 31.0ORD-XXXX425-01 (JP)ORD-XXX5703-01 (JP)

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
November 8, 2022
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
November 8, 2022
Hazard Level
HIGH
Brand
Foundation Medicine
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Foundation Medicine
Product type
Diagnostic Test
Model numbers
F1CDX - RAL-0003 version 31.0, ORD-XXXX425-01 (JP), ORD-XXX5703-01 (JP), ORD-XXXX467-01 (JP), ORD-XXXX474-01 (JP), ORD-XXXX460-01 (JP), ORD-XXXX612-01 (JP), ORD-XXXX484-01 (JP) +12 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    November 8, 2022

  2. Reported by FDA DEVICE

    December 3, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Reports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Foundation Medicine, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

The FoundationOne CDx is a genomic test that helps physicians make informed treatment decisions based on a patient's unique cancer profile. Patients typically use it to guide personalized therapy and improve treatment outcomes.

Why This Is Dangerous

The absence of the companion diagnostic Claims Page in the reports could lead to a lack of essential information for healthcare providers when making diagnosis and treatment decisions.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

The recall may affect patients' access to personalized treatment plans, potentially delaying necessary care.

Practical Guidance

How to identify if yours is affected

  1. Check your FoundationOne CDx report for the presence of the companion diagnostic Claims Page.
  2. Contact Foundation Medicine directly to clarify if your test result is part of the recall.
  3. Keep any correspondence from Foundation Medicine regarding your test for records.

Where to find product info

Look for the FoundationOne CDx model number on the test report provided to you by the healthcare provider.

What timeline to expect

Expect to receive a response regarding refunds or replacements within 4-6 weeks after contacting the manufacturer.

If the manufacturer is unresponsive

  • Contact Foundation Medicine customer service again if you do not hear back within the stated timeline.
  • File a complaint with the FDA if your issues remain unaddressed.

How to prevent similar issues

  • Inquire about the completeness of reports before using diagnostic tests in the future.
  • Ensure that any diagnostic tests are certified and follow proper regulations.

Documentation advice

Keep a copy of the test report and all related communications with Foundation Medicine for your records.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: FoundationOne CDx (F1CDx), RAL-0003 version 31.0 Quantity: 59 units (39 US, 20 OUS) Where Sold: Nationwide in the US and internationally, including Japan and Singapore Recall Date: November 8, 2022

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 59 units recalled (39 in the US, 20 international)
  • Missing companion diagnostic Claims Page in reports
  • No injuries or incidents reported
  • Stop using the device immediately
  • Contact Foundation Medicine for further instructions

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
F1CDX - RAL-0003 version 31.0
ORD-XXXX425-01 (JP)
ORD-XXX5703-01 (JP)
ORD-XXXX467-01 (JP)
ORD-XXXX474-01 (JP)
+15 more
Affected States
ALL
Report Date
December 3, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more